nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—endothelium—coronary artery disease	0.0217	0.315	CbGeAlD
Plerixafor—CXCR4—myocardium—coronary artery disease	0.0136	0.197	CbGeAlD
Plerixafor—CXCR4—heart—coronary artery disease	0.00948	0.138	CbGeAlD
Plerixafor—CXCR4—cardiovascular system—coronary artery disease	0.00895	0.13	CbGeAlD
Plerixafor—CXCR4—cardiac atrium—coronary artery disease	0.00811	0.118	CbGeAlD
Plerixafor—CXCR4—blood—coronary artery disease	0.00707	0.103	CbGeAlD
Plerixafor—Abdominal pain—Telmisartan—coronary artery disease	0.000401	0.000797	CcSEcCtD
Plerixafor—Dyspnoea—Losartan—coronary artery disease	0.000401	0.000796	CcSEcCtD
Plerixafor—Vomiting—Lovastatin—coronary artery disease	0.0004	0.000795	CcSEcCtD
Plerixafor—Dizziness—Eplerenone—coronary artery disease	0.000399	0.000793	CcSEcCtD
Plerixafor—Rash—Clopidogrel—coronary artery disease	0.000399	0.000793	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000399	0.000793	CcSEcCtD
Plerixafor—Dermatitis—Clopidogrel—coronary artery disease	0.000399	0.000792	CcSEcCtD
Plerixafor—Asthenia—Valsartan—coronary artery disease	0.000399	0.000792	CcSEcCtD
Plerixafor—Constipation—Furosemide—coronary artery disease	0.000398	0.000791	CcSEcCtD
Plerixafor—Pain—Furosemide—coronary artery disease	0.000398	0.000791	CcSEcCtD
Plerixafor—Hypersensitivity—Niacin—coronary artery disease	0.000398	0.000791	CcSEcCtD
Plerixafor—Ill-defined disorder—Lisinopril—coronary artery disease	0.000397	0.000789	CcSEcCtD
Plerixafor—Discomfort—Ramipril—coronary artery disease	0.000397	0.000789	CcSEcCtD
Plerixafor—Asthenia—Olmesartan—coronary artery disease	0.000397	0.000788	CcSEcCtD
Plerixafor—Headache—Clopidogrel—coronary artery disease	0.000397	0.000788	CcSEcCtD
Plerixafor—Rash—Lovastatin—coronary artery disease	0.000397	0.000788	CcSEcCtD
Plerixafor—Dermatitis—Lovastatin—coronary artery disease	0.000396	0.000787	CcSEcCtD
Plerixafor—Dyspepsia—Losartan—coronary artery disease	0.000396	0.000786	CcSEcCtD
Plerixafor—Feeling abnormal—Perindopril—coronary artery disease	0.000395	0.000784	CcSEcCtD
Plerixafor—Headache—Lovastatin—coronary artery disease	0.000394	0.000783	CcSEcCtD
Plerixafor—Pruritus—Valsartan—coronary artery disease	0.000393	0.000781	CcSEcCtD
Plerixafor—Dry mouth—Ramipril—coronary artery disease	0.000393	0.000781	CcSEcCtD
Plerixafor—Arthralgia—Timolol—coronary artery disease	0.000393	0.000781	CcSEcCtD
Plerixafor—Vomiting—Ezetimibe—coronary artery disease	0.000392	0.000779	CcSEcCtD
Plerixafor—Hypersensitivity—Pravastatin—coronary artery disease	0.000392	0.000779	CcSEcCtD
Plerixafor—Gastrointestinal pain—Perindopril—coronary artery disease	0.000392	0.000778	CcSEcCtD
Plerixafor—Pruritus—Olmesartan—coronary artery disease	0.000391	0.000777	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.00039	0.000775	CcSEcCtD
Plerixafor—Abdominal pain—Captopril—coronary artery disease	0.00039	0.000775	CcSEcCtD
Plerixafor—Dizziness—Simvastatin—coronary artery disease	0.000389	0.000773	CcSEcCtD
Plerixafor—Rash—Ezetimibe—coronary artery disease	0.000389	0.000773	CcSEcCtD
Plerixafor—Dermatitis—Ezetimibe—coronary artery disease	0.000389	0.000772	CcSEcCtD
Plerixafor—Discomfort—Timolol—coronary artery disease	0.000388	0.000771	CcSEcCtD
Plerixafor—Asthenia—Niacin—coronary artery disease	0.000388	0.00077	CcSEcCtD
Plerixafor—Fatigue—Losartan—coronary artery disease	0.000387	0.00077	CcSEcCtD
Plerixafor—Headache—Ezetimibe—coronary artery disease	0.000387	0.000768	CcSEcCtD
Plerixafor—Malaise—Lisinopril—coronary artery disease	0.000386	0.000767	CcSEcCtD
Plerixafor—Anaphylactic shock—Ramipril—coronary artery disease	0.000385	0.000765	CcSEcCtD
Plerixafor—Dry mouth—Timolol—coronary artery disease	0.000384	0.000763	CcSEcCtD
Plerixafor—Pain—Losartan—coronary artery disease	0.000384	0.000763	CcSEcCtD
Plerixafor—Constipation—Losartan—coronary artery disease	0.000384	0.000763	CcSEcCtD
Plerixafor—Syncope—Lisinopril—coronary artery disease	0.000384	0.000763	CcSEcCtD
Plerixafor—Vomiting—Eplerenone—coronary artery disease	0.000384	0.000763	CcSEcCtD
Plerixafor—Feeling abnormal—Furosemide—coronary artery disease	0.000384	0.000762	CcSEcCtD
Plerixafor—Nausea—Fenofibrate—coronary artery disease	0.000383	0.00076	CcSEcCtD
Plerixafor—Pruritus—Niacin—coronary artery disease	0.000382	0.000759	CcSEcCtD
Plerixafor—Asthenia—Pravastatin—coronary artery disease	0.000382	0.000758	CcSEcCtD
Plerixafor—Gastrointestinal pain—Furosemide—coronary artery disease	0.000381	0.000757	CcSEcCtD
Plerixafor—Rash—Eplerenone—coronary artery disease	0.000381	0.000756	CcSEcCtD
Plerixafor—Urticaria—Perindopril—coronary artery disease	0.000381	0.000756	CcSEcCtD
Plerixafor—Hypersensitivity—Trandolapril—coronary artery disease	0.000381	0.000756	CcSEcCtD
Plerixafor—Dermatitis—Eplerenone—coronary artery disease	0.00038	0.000756	CcSEcCtD
Plerixafor—Diarrhoea—Valsartan—coronary artery disease	0.00038	0.000755	CcSEcCtD
Plerixafor—Shock—Ramipril—coronary artery disease	0.000379	0.000753	CcSEcCtD
Plerixafor—Hypersensitivity—Enalapril—coronary artery disease	0.000379	0.000753	CcSEcCtD
Plerixafor—Abdominal pain—Perindopril—coronary artery disease	0.000379	0.000752	CcSEcCtD
Plerixafor—Diarrhoea—Olmesartan—coronary artery disease	0.000378	0.000752	CcSEcCtD
Plerixafor—Headache—Eplerenone—coronary artery disease	0.000378	0.000752	CcSEcCtD
Plerixafor—Nervous system disorder—Ramipril—coronary artery disease	0.000378	0.000751	CcSEcCtD
Plerixafor—Anaphylactic shock—Timolol—coronary artery disease	0.000377	0.000748	CcSEcCtD
Plerixafor—Pruritus—Pravastatin—coronary artery disease	0.000376	0.000748	CcSEcCtD
Plerixafor—Loss of consciousness—Lisinopril—coronary artery disease	0.000376	0.000748	CcSEcCtD
Plerixafor—Nausea—Clopidogrel—coronary artery disease	0.000376	0.000747	CcSEcCtD
Plerixafor—Skin disorder—Ramipril—coronary artery disease	0.000374	0.000744	CcSEcCtD
Plerixafor—Vomiting—Simvastatin—coronary artery disease	0.000374	0.000743	CcSEcCtD
Plerixafor—Hypersensitivity—Telmisartan—coronary artery disease	0.000374	0.000743	CcSEcCtD
Plerixafor—Nausea—Lovastatin—coronary artery disease	0.000374	0.000742	CcSEcCtD
Plerixafor—Hyperhidrosis—Ramipril—coronary artery disease	0.000373	0.00074	CcSEcCtD
Plerixafor—Rash—Simvastatin—coronary artery disease	0.000371	0.000737	CcSEcCtD
Plerixafor—Dermatitis—Simvastatin—coronary artery disease	0.000371	0.000736	CcSEcCtD
Plerixafor—Asthenia—Trandolapril—coronary artery disease	0.000371	0.000736	CcSEcCtD
Plerixafor—Shock—Timolol—coronary artery disease	0.000371	0.000736	CcSEcCtD
Plerixafor—Feeling abnormal—Losartan—coronary artery disease	0.00037	0.000736	CcSEcCtD
Plerixafor—Urticaria—Furosemide—coronary artery disease	0.00037	0.000735	CcSEcCtD
Plerixafor—Diarrhoea—Niacin—coronary artery disease	0.00037	0.000734	CcSEcCtD
Plerixafor—Nervous system disorder—Timolol—coronary artery disease	0.000369	0.000734	CcSEcCtD
Plerixafor—Asthenia—Enalapril—coronary artery disease	0.000369	0.000733	CcSEcCtD
Plerixafor—Headache—Simvastatin—coronary artery disease	0.000369	0.000732	CcSEcCtD
Plerixafor—Abdominal pain—Furosemide—coronary artery disease	0.000368	0.000731	CcSEcCtD
Plerixafor—Gastrointestinal pain—Losartan—coronary artery disease	0.000367	0.00073	CcSEcCtD
Plerixafor—Dizziness—Valsartan—coronary artery disease	0.000367	0.00073	CcSEcCtD
Plerixafor—Nausea—Ezetimibe—coronary artery disease	0.000366	0.000728	CcSEcCtD
Plerixafor—Skin disorder—Timolol—coronary artery disease	0.000366	0.000727	CcSEcCtD
Plerixafor—Dizziness—Olmesartan—coronary artery disease	0.000366	0.000726	CcSEcCtD
Plerixafor—Pruritus—Trandolapril—coronary artery disease	0.000365	0.000726	CcSEcCtD
Plerixafor—Arthralgia—Lisinopril—coronary artery disease	0.000365	0.000724	CcSEcCtD
Plerixafor—Hyperhidrosis—Timolol—coronary artery disease	0.000364	0.000723	CcSEcCtD
Plerixafor—Asthenia—Telmisartan—coronary artery disease	0.000364	0.000723	CcSEcCtD
Plerixafor—Pruritus—Enalapril—coronary artery disease	0.000364	0.000723	CcSEcCtD
Plerixafor—Diarrhoea—Pravastatin—coronary artery disease	0.000364	0.000723	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000362	0.000719	CcSEcCtD
Plerixafor—Discomfort—Lisinopril—coronary artery disease	0.00036	0.000715	CcSEcCtD
Plerixafor—Pruritus—Telmisartan—coronary artery disease	0.000359	0.000713	CcSEcCtD
Plerixafor—Nausea—Eplerenone—coronary artery disease	0.000359	0.000713	CcSEcCtD
Plerixafor—Dizziness—Niacin—coronary artery disease	0.000357	0.00071	CcSEcCtD
Plerixafor—Urticaria—Losartan—coronary artery disease	0.000357	0.000709	CcSEcCtD
Plerixafor—Dry mouth—Lisinopril—coronary artery disease	0.000357	0.000708	CcSEcCtD
Plerixafor—Abdominal pain—Losartan—coronary artery disease	0.000355	0.000706	CcSEcCtD
Plerixafor—Asthenia—Captopril—coronary artery disease	0.000354	0.000703	CcSEcCtD
Plerixafor—Diarrhoea—Trandolapril—coronary artery disease	0.000353	0.000702	CcSEcCtD
Plerixafor—Vomiting—Valsartan—coronary artery disease	0.000353	0.000702	CcSEcCtD
Plerixafor—Diarrhoea—Enalapril—coronary artery disease	0.000352	0.000699	CcSEcCtD
Plerixafor—Dizziness—Pravastatin—coronary artery disease	0.000352	0.000699	CcSEcCtD
Plerixafor—Vomiting—Olmesartan—coronary artery disease	0.000352	0.000698	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000351	0.000697	CcSEcCtD
Plerixafor—Rash—Valsartan—coronary artery disease	0.00035	0.000696	CcSEcCtD
Plerixafor—Dermatitis—Valsartan—coronary artery disease	0.00035	0.000695	CcSEcCtD
Plerixafor—Nausea—Simvastatin—coronary artery disease	0.000349	0.000694	CcSEcCtD
Plerixafor—Anaphylactic shock—Lisinopril—coronary artery disease	0.000349	0.000694	CcSEcCtD
Plerixafor—Pruritus—Captopril—coronary artery disease	0.000349	0.000694	CcSEcCtD
Plerixafor—Rash—Olmesartan—coronary artery disease	0.000349	0.000693	CcSEcCtD
Plerixafor—Insomnia—Ramipril—coronary artery disease	0.000349	0.000692	CcSEcCtD
Plerixafor—Dermatitis—Olmesartan—coronary artery disease	0.000348	0.000692	CcSEcCtD
Plerixafor—Headache—Valsartan—coronary artery disease	0.000348	0.000691	CcSEcCtD
Plerixafor—Diarrhoea—Telmisartan—coronary artery disease	0.000347	0.00069	CcSEcCtD
Plerixafor—Headache—Olmesartan—coronary artery disease	0.000346	0.000688	CcSEcCtD
Plerixafor—Paraesthesia—Ramipril—coronary artery disease	0.000346	0.000687	CcSEcCtD
Plerixafor—Shock—Lisinopril—coronary artery disease	0.000344	0.000683	CcSEcCtD
Plerixafor—Asthenia—Perindopril—coronary artery disease	0.000344	0.000683	CcSEcCtD
Plerixafor—Dyspnoea—Ramipril—coronary artery disease	0.000344	0.000682	CcSEcCtD
Plerixafor—Vomiting—Niacin—coronary artery disease	0.000344	0.000682	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000343	0.000682	CcSEcCtD
Plerixafor—Hypersensitivity—Furosemide—coronary artery disease	0.000343	0.000682	CcSEcCtD
Plerixafor—Dizziness—Trandolapril—coronary artery disease	0.000342	0.000679	CcSEcCtD
Plerixafor—Insomnia—Timolol—coronary artery disease	0.000341	0.000677	CcSEcCtD
Plerixafor—Rash—Niacin—coronary artery disease	0.000341	0.000677	CcSEcCtD
Plerixafor—Dermatitis—Niacin—coronary artery disease	0.00034	0.000676	CcSEcCtD
Plerixafor—Dizziness—Enalapril—coronary artery disease	0.00034	0.000676	CcSEcCtD
Plerixafor—Skin disorder—Lisinopril—coronary artery disease	0.000339	0.000674	CcSEcCtD
Plerixafor—Dyspepsia—Ramipril—coronary artery disease	0.000339	0.000674	CcSEcCtD
Plerixafor—Pruritus—Perindopril—coronary artery disease	0.000339	0.000673	CcSEcCtD
Plerixafor—Headache—Niacin—coronary artery disease	0.000338	0.000672	CcSEcCtD
Plerixafor—Paraesthesia—Timolol—coronary artery disease	0.000338	0.000672	CcSEcCtD
Plerixafor—Vomiting—Pravastatin—coronary artery disease	0.000338	0.000672	CcSEcCtD
Plerixafor—Hyperhidrosis—Lisinopril—coronary artery disease	0.000338	0.000671	CcSEcCtD
Plerixafor—Diarrhoea—Captopril—coronary artery disease	0.000338	0.000671	CcSEcCtD
Plerixafor—Dyspnoea—Timolol—coronary artery disease	0.000336	0.000667	CcSEcCtD
Plerixafor—Dizziness—Telmisartan—coronary artery disease	0.000336	0.000667	CcSEcCtD
Plerixafor—Rash—Pravastatin—coronary artery disease	0.000335	0.000666	CcSEcCtD
Plerixafor—Dermatitis—Pravastatin—coronary artery disease	0.000335	0.000666	CcSEcCtD
Plerixafor—Asthenia—Furosemide—coronary artery disease	0.000334	0.000664	CcSEcCtD
Plerixafor—Headache—Pravastatin—coronary artery disease	0.000333	0.000662	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000333	0.000661	CcSEcCtD
Plerixafor—Fatigue—Ramipril—coronary artery disease	0.000332	0.00066	CcSEcCtD
Plerixafor—Dyspepsia—Timolol—coronary artery disease	0.000332	0.000659	CcSEcCtD
Plerixafor—Hypersensitivity—Losartan—coronary artery disease	0.000331	0.000658	CcSEcCtD
Plerixafor—Nausea—Valsartan—coronary artery disease	0.00033	0.000656	CcSEcCtD
Plerixafor—Pruritus—Furosemide—coronary artery disease	0.00033	0.000655	CcSEcCtD
Plerixafor—Constipation—Ramipril—coronary artery disease	0.00033	0.000655	CcSEcCtD
Plerixafor—Nausea—Olmesartan—coronary artery disease	0.000328	0.000652	CcSEcCtD
Plerixafor—Vomiting—Trandolapril—coronary artery disease	0.000328	0.000652	CcSEcCtD
Plerixafor—Diarrhoea—Perindopril—coronary artery disease	0.000328	0.000651	CcSEcCtD
Plerixafor—Vomiting—Enalapril—coronary artery disease	0.000327	0.00065	CcSEcCtD
Plerixafor—Dizziness—Captopril—coronary artery disease	0.000326	0.000648	CcSEcCtD
Plerixafor—Rash—Trandolapril—coronary artery disease	0.000326	0.000647	CcSEcCtD
Plerixafor—Dermatitis—Trandolapril—coronary artery disease	0.000325	0.000646	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Timolol—coronary artery disease	0.000325	0.000646	CcSEcCtD
Plerixafor—Fatigue—Timolol—coronary artery disease	0.000325	0.000645	CcSEcCtD
Plerixafor—Rash—Enalapril—coronary artery disease	0.000324	0.000644	CcSEcCtD
Plerixafor—Dermatitis—Enalapril—coronary artery disease	0.000324	0.000644	CcSEcCtD
Plerixafor—Headache—Trandolapril—coronary artery disease	0.000324	0.000643	CcSEcCtD
Plerixafor—Vomiting—Telmisartan—coronary artery disease	0.000323	0.000641	CcSEcCtD
Plerixafor—Asthenia—Losartan—coronary artery disease	0.000322	0.00064	CcSEcCtD
Plerixafor—Headache—Enalapril—coronary artery disease	0.000322	0.00064	CcSEcCtD
Plerixafor—Pain—Timolol—coronary artery disease	0.000322	0.00064	CcSEcCtD
Plerixafor—Nausea—Niacin—coronary artery disease	0.000321	0.000637	CcSEcCtD
Plerixafor—Rash—Telmisartan—coronary artery disease	0.00032	0.000636	CcSEcCtD
Plerixafor—Dermatitis—Telmisartan—coronary artery disease	0.00032	0.000635	CcSEcCtD
Plerixafor—Diarrhoea—Furosemide—coronary artery disease	0.000319	0.000633	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000318	0.000632	CcSEcCtD
Plerixafor—Pruritus—Losartan—coronary artery disease	0.000318	0.000632	CcSEcCtD
Plerixafor—Headache—Telmisartan—coronary artery disease	0.000318	0.000632	CcSEcCtD
Plerixafor—Feeling abnormal—Ramipril—coronary artery disease	0.000318	0.000631	CcSEcCtD
Plerixafor—Dizziness—Perindopril—coronary artery disease	0.000317	0.000629	CcSEcCtD
Plerixafor—Insomnia—Lisinopril—coronary artery disease	0.000316	0.000628	CcSEcCtD
Plerixafor—Nausea—Pravastatin—coronary artery disease	0.000316	0.000628	CcSEcCtD
Plerixafor—Gastrointestinal pain—Ramipril—coronary artery disease	0.000315	0.000626	CcSEcCtD
Plerixafor—Paraesthesia—Lisinopril—coronary artery disease	0.000314	0.000623	CcSEcCtD
Plerixafor—Vomiting—Captopril—coronary artery disease	0.000314	0.000623	CcSEcCtD
Plerixafor—Dyspnoea—Lisinopril—coronary artery disease	0.000312	0.000619	CcSEcCtD
Plerixafor—Rash—Captopril—coronary artery disease	0.000311	0.000618	CcSEcCtD
Plerixafor—Dermatitis—Captopril—coronary artery disease	0.000311	0.000617	CcSEcCtD
Plerixafor—Feeling abnormal—Timolol—coronary artery disease	0.00031	0.000617	CcSEcCtD
Plerixafor—Headache—Captopril—coronary artery disease	0.000309	0.000614	CcSEcCtD
Plerixafor—Gastrointestinal pain—Timolol—coronary artery disease	0.000308	0.000612	CcSEcCtD
Plerixafor—Dizziness—Furosemide—coronary artery disease	0.000308	0.000612	CcSEcCtD
Plerixafor—Dyspepsia—Lisinopril—coronary artery disease	0.000308	0.000611	CcSEcCtD
Plerixafor—Diarrhoea—Losartan—coronary artery disease	0.000307	0.000611	CcSEcCtD
Plerixafor—Nausea—Trandolapril—coronary artery disease	0.000307	0.00061	CcSEcCtD
Plerixafor—Urticaria—Ramipril—coronary artery disease	0.000306	0.000608	CcSEcCtD
Plerixafor—Nausea—Enalapril—coronary artery disease	0.000306	0.000607	CcSEcCtD
Plerixafor—Vomiting—Perindopril—coronary artery disease	0.000305	0.000605	CcSEcCtD
Plerixafor—Abdominal pain—Ramipril—coronary artery disease	0.000305	0.000605	CcSEcCtD
Plerixafor—Rash—Perindopril—coronary artery disease	0.000302	0.0006	CcSEcCtD
Plerixafor—Dermatitis—Perindopril—coronary artery disease	0.000302	0.0006	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000302	0.000599	CcSEcCtD
Plerixafor—Nausea—Telmisartan—coronary artery disease	0.000301	0.000599	CcSEcCtD
Plerixafor—Fatigue—Lisinopril—coronary artery disease	0.000301	0.000599	CcSEcCtD
Plerixafor—Headache—Perindopril—coronary artery disease	0.0003	0.000596	CcSEcCtD
Plerixafor—Urticaria—Timolol—coronary artery disease	0.000299	0.000594	CcSEcCtD
Plerixafor—Pain—Lisinopril—coronary artery disease	0.000299	0.000594	CcSEcCtD
Plerixafor—Constipation—Lisinopril—coronary artery disease	0.000299	0.000594	CcSEcCtD
Plerixafor—Abdominal pain—Timolol—coronary artery disease	0.000298	0.000592	CcSEcCtD
Plerixafor—Dizziness—Losartan—coronary artery disease	0.000297	0.00059	CcSEcCtD
Plerixafor—Vomiting—Furosemide—coronary artery disease	0.000296	0.000588	CcSEcCtD
Plerixafor—Rash—Furosemide—coronary artery disease	0.000294	0.000583	CcSEcCtD
Plerixafor—Dermatitis—Furosemide—coronary artery disease	0.000293	0.000583	CcSEcCtD
Plerixafor—Nausea—Captopril—coronary artery disease	0.000293	0.000582	CcSEcCtD
Plerixafor—Headache—Furosemide—coronary artery disease	0.000292	0.00058	CcSEcCtD
Plerixafor—Feeling abnormal—Lisinopril—coronary artery disease	0.000288	0.000572	CcSEcCtD
Plerixafor—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000286	0.000568	CcSEcCtD
Plerixafor—Vomiting—Losartan—coronary artery disease	0.000286	0.000568	CcSEcCtD
Plerixafor—Nausea—Perindopril—coronary artery disease	0.000285	0.000565	CcSEcCtD
Plerixafor—Hypersensitivity—Ramipril—coronary artery disease	0.000284	0.000564	CcSEcCtD
Plerixafor—Rash—Losartan—coronary artery disease	0.000283	0.000563	CcSEcCtD
Plerixafor—Dermatitis—Losartan—coronary artery disease	0.000283	0.000562	CcSEcCtD
Plerixafor—Headache—Losartan—coronary artery disease	0.000282	0.000559	CcSEcCtD
Plerixafor—Urticaria—Lisinopril—coronary artery disease	0.000278	0.000551	CcSEcCtD
Plerixafor—Hypersensitivity—Timolol—coronary artery disease	0.000278	0.000551	CcSEcCtD
Plerixafor—Nausea—Furosemide—coronary artery disease	0.000277	0.00055	CcSEcCtD
Plerixafor—Asthenia—Ramipril—coronary artery disease	0.000276	0.000549	CcSEcCtD
Plerixafor—Abdominal pain—Lisinopril—coronary artery disease	0.000276	0.000549	CcSEcCtD
Plerixafor—Pruritus—Ramipril—coronary artery disease	0.000273	0.000542	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—HTR2A—coronary artery disease	0.000271	0.000633	CbGpPWpGaD
Plerixafor—Asthenia—Timolol—coronary artery disease	0.00027	0.000537	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—C3—coronary artery disease	0.00027	0.000632	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL2—coronary artery disease	0.000268	0.000627	CbGpPWpGaD
Plerixafor—Nausea—Losartan—coronary artery disease	0.000267	0.00053	CcSEcCtD
Plerixafor—Pruritus—Timolol—coronary artery disease	0.000267	0.000529	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—NEDD4—coronary artery disease	0.000266	0.000623	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—F2R—coronary artery disease	0.000265	0.00062	CbGpPWpGaD
Plerixafor—Diarrhoea—Ramipril—coronary artery disease	0.000264	0.000524	CcSEcCtD
Plerixafor—CXCR4—Disease—NR4A1—coronary artery disease	0.000262	0.000613	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MDK—coronary artery disease	0.00026	0.000607	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PF4—coronary artery disease	0.00026	0.000607	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RAMP2—coronary artery disease	0.00026	0.000607	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDE3A—coronary artery disease	0.00026	0.000607	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HDAC9—coronary artery disease	0.00026	0.000607	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR3—coronary artery disease	0.000259	0.000606	CbGpPWpGaD
Plerixafor—Diarrhoea—Timolol—coronary artery disease	0.000258	0.000512	CcSEcCtD
Plerixafor—Hypersensitivity—Lisinopril—coronary artery disease	0.000257	0.000511	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—EDNRB—coronary artery disease	0.000257	0.000601	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AGT—coronary artery disease	0.000257	0.0006	CbGpPWpGaD
Plerixafor—Dizziness—Ramipril—coronary artery disease	0.000255	0.000506	CcSEcCtD
Plerixafor—CXCR4—Disease—P4HB—coronary artery disease	0.000252	0.000589	CbGpPWpGaD
Plerixafor—Asthenia—Lisinopril—coronary artery disease	0.000251	0.000498	CcSEcCtD
Plerixafor—Dizziness—Timolol—coronary artery disease	0.000249	0.000495	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—F2RL1—coronary artery disease	0.000248	0.000579	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RALBP1—coronary artery disease	0.000248	0.000579	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY5R—coronary artery disease	0.000248	0.000579	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPP3R1—coronary artery disease	0.000247	0.000578	CbGpPWpGaD
Plerixafor—Pruritus—Lisinopril—coronary artery disease	0.000247	0.000491	CcSEcCtD
Plerixafor—Vomiting—Ramipril—coronary artery disease	0.000245	0.000487	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL3—coronary artery disease	0.000244	0.000569	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL2—coronary artery disease	0.000244	0.000569	CbGpPWpGaD
Plerixafor—Rash—Ramipril—coronary artery disease	0.000243	0.000483	CcSEcCtD
Plerixafor—Dermatitis—Ramipril—coronary artery disease	0.000243	0.000482	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—EDNRA—coronary artery disease	0.000243	0.000567	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB1—coronary artery disease	0.000241	0.000565	CbGpPWpGaD
Plerixafor—Headache—Ramipril—coronary artery disease	0.000241	0.00048	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—F2R—coronary artery disease	0.000241	0.000563	CbGpPWpGaD
Plerixafor—Vomiting—Timolol—coronary artery disease	0.00024	0.000476	CcSEcCtD
Plerixafor—Diarrhoea—Lisinopril—coronary artery disease	0.000239	0.000475	CcSEcCtD
Plerixafor—CXCR4—Disease—NPPA—coronary artery disease	0.000239	0.000559	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CYBB—coronary artery disease	0.000239	0.000559	CbGpPWpGaD
Plerixafor—Rash—Timolol—coronary artery disease	0.000238	0.000472	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—FZD2—coronary artery disease	0.000237	0.000555	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—UTS2R—coronary artery disease	0.000237	0.000555	CbGpPWpGaD
Plerixafor—Dermatitis—Timolol—coronary artery disease	0.000237	0.000471	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—F2—coronary artery disease	0.000237	0.000555	CbGpPWpGaD
Plerixafor—Headache—Timolol—coronary artery disease	0.000236	0.000469	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—EDNRB—coronary artery disease	0.000233	0.000545	CbGpPWpGaD
Plerixafor—CXCR4—Disease—VCAN—coronary artery disease	0.000233	0.000545	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MAP2K3—coronary artery disease	0.000233	0.000545	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SFRP2—coronary artery disease	0.000233	0.000545	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ALDOA—coronary artery disease	0.000231	0.000541	CbGpPWpGaD
Plerixafor—Dizziness—Lisinopril—coronary artery disease	0.000231	0.000459	CcSEcCtD
Plerixafor—Nausea—Ramipril—coronary artery disease	0.000229	0.000455	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ADORA1—coronary artery disease	0.000229	0.000534	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOA4—coronary artery disease	0.000229	0.000534	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADORA3—coronary artery disease	0.000229	0.000534	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000228	0.000533	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL12—coronary artery disease	0.000228	0.000533	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CST3—coronary artery disease	0.000226	0.000529	CbGpPWpGaD
Plerixafor—CXCR4—Disease—DCN—coronary artery disease	0.000225	0.000525	CbGpPWpGaD
Plerixafor—Nausea—Timolol—coronary artery disease	0.000224	0.000444	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—PLCB1—coronary artery disease	0.000223	0.000521	CbGpPWpGaD
Plerixafor—Vomiting—Lisinopril—coronary artery disease	0.000222	0.000441	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PPBP—coronary artery disease	0.000221	0.000516	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PGF—coronary artery disease	0.000221	0.000516	CbGpPWpGaD
Plerixafor—Rash—Lisinopril—coronary artery disease	0.00022	0.000438	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—EDNRA—coronary artery disease	0.00022	0.000515	CbGpPWpGaD
Plerixafor—Dermatitis—Lisinopril—coronary artery disease	0.00022	0.000437	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.00022	0.000513	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADRB1—coronary artery disease	0.000219	0.000513	CbGpPWpGaD
Plerixafor—Headache—Lisinopril—coronary artery disease	0.000219	0.000435	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—HTR7—coronary artery disease	0.000218	0.000511	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DVL1—coronary artery disease	0.000217	0.000508	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ITGA2B—coronary artery disease	0.000217	0.000508	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—POMC—coronary artery disease	0.000216	0.000505	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOC3—coronary artery disease	0.000212	0.000495	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—coronary artery disease	0.000211	0.000495	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—OPRD1—coronary artery disease	0.000211	0.000492	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GHR—coronary artery disease	0.000211	0.000492	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL4—coronary artery disease	0.000211	0.000492	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LDLR—coronary artery disease	0.00021	0.000492	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC9A1—coronary artery disease	0.000208	0.000486	CbGpPWpGaD
Plerixafor—Nausea—Lisinopril—coronary artery disease	0.000208	0.000412	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—KNG1—coronary artery disease	0.000207	0.000485	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL12—coronary artery disease	0.000207	0.000484	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—BDKRB2—coronary artery disease	0.000207	0.000484	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGTR1—coronary artery disease	0.000206	0.000482	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SDC1—coronary artery disease	0.000203	0.000475	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PLCB1—coronary artery disease	0.000203	0.000474	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MEF2A—coronary artery disease	0.000202	0.000472	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TLE4—coronary artery disease	0.000202	0.000472	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL10—coronary artery disease	0.000202	0.000471	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR7—coronary artery disease	0.000198	0.000464	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOA2—coronary artery disease	0.000197	0.00046	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB2—coronary artery disease	0.000196	0.000457	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AVPR1A—coronary artery disease	0.000194	0.000454	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCE—coronary artery disease	0.000193	0.000452	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PSMA6—coronary artery disease	0.000192	0.000449	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PSMB5—coronary artery disease	0.000192	0.000449	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—KNG1—coronary artery disease	0.000188	0.000441	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—UTS2—coronary artery disease	0.000188	0.000439	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGTR1—coronary artery disease	0.000187	0.000438	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GOT2—coronary artery disease	0.000186	0.000434	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CYBA—coronary artery disease	0.000185	0.000433	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CALR—coronary artery disease	0.000184	0.000431	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NR4A1—coronary artery disease	0.000184	0.00043	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL10—coronary artery disease	0.000183	0.000428	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLCB3—coronary artery disease	0.000182	0.000425	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HDAC9—coronary artery disease	0.000182	0.000425	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—P2RY12—coronary artery disease	0.000182	0.000425	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASR—coronary artery disease	0.00018	0.000421	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CX3CR1—coronary artery disease	0.00018	0.000421	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADRB2—coronary artery disease	0.000178	0.000415	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CX3CL1—coronary artery disease	0.000176	0.000413	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BDKRB1—coronary artery disease	0.000176	0.000413	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—P4HB—coronary artery disease	0.000176	0.000413	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNA12—coronary artery disease	0.000176	0.000413	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCE—coronary artery disease	0.000175	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—EDN1—coronary artery disease	0.000175	0.000409	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCL5—coronary artery disease	0.000173	0.000406	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPP3R1—coronary artery disease	0.000173	0.000405	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADM—coronary artery disease	0.000172	0.000401	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HSPA1A—coronary artery disease	0.000171	0.000401	CbGpPWpGaD
Plerixafor—CXCR4—Disease—JUNB—coronary artery disease	0.000171	0.000401	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CSF2—coronary artery disease	0.000171	0.0004	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDE4B—coronary artery disease	0.000167	0.000391	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CYBB—coronary artery disease	0.000167	0.000391	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—coronary artery disease	0.000167	0.000391	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MMP3—coronary artery disease	0.000167	0.00039	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GOT1—coronary artery disease	0.00016	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EDN1—coronary artery disease	0.000159	0.000371	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL5—coronary artery disease	0.000158	0.000368	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCD—coronary artery disease	0.000156	0.000365	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CSF2—coronary artery disease	0.000155	0.000363	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR3—coronary artery disease	0.000153	0.000358	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2A—coronary artery disease	0.000153	0.000358	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—C3—coronary artery disease	0.000153	0.000357	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRK—coronary artery disease	0.000151	0.000353	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VWF—coronary artery disease	0.000149	0.000349	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SH2B3—coronary artery disease	0.000149	0.000349	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ATP2A2—coronary artery disease	0.000149	0.000349	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOC3—coronary artery disease	0.000148	0.000347	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRKCE—coronary artery disease	0.000148	0.000346	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LDLR—coronary artery disease	0.000147	0.000344	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGT—coronary artery disease	0.000145	0.000339	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PPP2CA—coronary artery disease	0.000145	0.000338	CbGpPWpGaD
Plerixafor—CXCR4—Disease—KITLG—coronary artery disease	0.000144	0.000337	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFBR2—coronary artery disease	0.000144	0.000337	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL3—coronary artery disease	0.000144	0.000336	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL2—coronary artery disease	0.000144	0.000336	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—F2R—coronary artery disease	0.000142	0.000333	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SDC1—coronary artery disease	0.000142	0.000333	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCD—coronary artery disease	0.000142	0.000332	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT5A—coronary artery disease	0.000141	0.000329	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGB—coronary artery disease	0.000139	0.000326	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2A—coronary artery disease	0.000139	0.000325	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—C3—coronary artery disease	0.000139	0.000324	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDNRB—coronary artery disease	0.000138	0.000322	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOB—coronary artery disease	0.000136	0.000318	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—THBS1—coronary artery disease	0.000136	0.000317	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSMA6—coronary artery disease	0.000134	0.000314	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSMB5—coronary artery disease	0.000134	0.000314	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—F2—coronary artery disease	0.000134	0.000314	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGT—coronary artery disease	0.000132	0.000308	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FGF1—coronary artery disease	0.000131	0.000306	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDNRA—coronary artery disease	0.00013	0.000304	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LPL—coronary artery disease	0.00013	0.000304	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRB1—coronary artery disease	0.00013	0.000303	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CYBA—coronary artery disease	0.00013	0.000303	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DUSP6—coronary artery disease	0.000129	0.000302	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLAT—coronary artery disease	0.000127	0.000296	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BDKRB2—coronary artery disease	0.000122	0.000286	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL12—coronary artery disease	0.000122	0.000286	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—coronary artery disease	0.000122	0.000286	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPP2CA—coronary artery disease	0.000122	0.000285	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—F2—coronary artery disease	0.000122	0.000285	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6ST—coronary artery disease	0.000121	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JUNB—coronary artery disease	0.00012	0.000281	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRKCD—coronary artery disease	0.00012	0.00028	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLCB1—coronary artery disease	0.00012	0.00028	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR7—coronary artery disease	0.000117	0.000274	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTHFR—coronary artery disease	0.000117	0.000274	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ITGAV—coronary artery disease	0.000112	0.000261	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HIF1A—coronary artery disease	0.000112	0.000261	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KNG1—coronary artery disease	0.000111	0.00026	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—coronary artery disease	0.000111	0.000259	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CREB1—coronary artery disease	0.000111	0.000259	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGTR1—coronary artery disease	0.000111	0.000259	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOE—coronary artery disease	0.000109	0.000255	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—coronary artery disease	0.000109	0.000254	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6R—coronary artery disease	0.000108	0.000253	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL10—coronary artery disease	0.000108	0.000253	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLG—coronary artery disease	0.000108	0.000252	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOA1—coronary artery disease	0.000108	0.000252	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRB2—coronary artery disease	0.000105	0.000245	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCE—coronary artery disease	0.000104	0.000242	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—JAK2—coronary artery disease	0.000104	0.000242	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SOCS1—coronary artery disease	0.000103	0.000242	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—S100B—coronary artery disease	0.000103	0.000241	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6ST—coronary artery disease	0.000102	0.000239	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SOCS3—coronary artery disease	0.000102	0.000239	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS2—coronary artery disease	0.000102	0.000237	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFBR2—coronary artery disease	0.000101	0.000236	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KITLG—coronary artery disease	0.000101	0.000236	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP3—coronary artery disease	9.86e-05	0.000231	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT5A—coronary artery disease	9.86e-05	0.000231	CbGpPWpGaD
Plerixafor—CXCR4—Disease—KIT—coronary artery disease	9.83e-05	0.00023	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOB—coronary artery disease	9.53e-05	0.000223	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—coronary artery disease	9.45e-05	0.000221	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GSK3B—coronary artery disease	9.43e-05	0.000221	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—JAK2—coronary artery disease	9.4e-05	0.00022	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EDN1—coronary artery disease	9.38e-05	0.000219	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CREB1—coronary artery disease	9.36e-05	0.000219	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL5—coronary artery disease	9.31e-05	0.000218	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGF1—coronary artery disease	9.17e-05	0.000214	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CSF2—coronary artery disease	9.17e-05	0.000214	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6R—coronary artery disease	9.13e-05	0.000213	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LPL—coronary artery disease	9.1e-05	0.000213	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MEF2C—coronary artery disease	9.02e-05	0.000211	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RPS6KB1—coronary artery disease	9.02e-05	0.000211	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ITGB3—coronary artery disease	8.79e-05	0.000206	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—coronary artery disease	8.58e-05	0.000201	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SERPINE1—coronary artery disease	8.55e-05	0.0002	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPP2CA—coronary artery disease	8.54e-05	0.0002	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCD—coronary artery disease	8.38e-05	0.000196	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FGF2—coronary artery disease	8.27e-05	0.000193	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2A—coronary artery disease	8.2e-05	0.000192	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C3—coronary artery disease	8.19e-05	0.000192	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS3—coronary artery disease	8.16e-05	0.000191	CbGpPWpGaD
Plerixafor—CXCR4—Disease—JAK2—coronary artery disease	7.93e-05	0.000185	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HIF1A—coronary artery disease	7.81e-05	0.000183	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGT—coronary artery disease	7.78e-05	0.000182	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—coronary artery disease	7.63e-05	0.000178	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEP—coronary artery disease	7.63e-05	0.000178	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOA1—coronary artery disease	7.54e-05	0.000176	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KDR—coronary artery disease	7.47e-05	0.000175	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—coronary artery disease	7.46e-05	0.000175	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK14—coronary artery disease	7.42e-05	0.000174	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ESR1—coronary artery disease	7.28e-05	0.00017	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FN1—coronary artery disease	7.19e-05	0.000168	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—F2—coronary artery disease	7.19e-05	0.000168	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6ST—coronary artery disease	7.16e-05	0.000168	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NFKBIA—coronary artery disease	7.11e-05	0.000166	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KIT—coronary artery disease	6.88e-05	0.000161	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GSK3B—coronary artery disease	6.61e-05	0.000154	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CREB1—coronary artery disease	6.55e-05	0.000153	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—coronary artery disease	6.55e-05	0.000153	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—coronary artery disease	6.41e-05	0.00015	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6R—coronary artery disease	6.39e-05	0.000149	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1—coronary artery disease	6.3e-05	0.000147	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MAPK1—coronary artery disease	6.27e-05	0.000147	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CA—coronary artery disease	5.99e-05	0.00014	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SERPINE1—coronary artery disease	5.99e-05	0.00014	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGF2—coronary artery disease	5.79e-05	0.000135	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOS3—coronary artery disease	5.71e-05	0.000134	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JAK2—coronary artery disease	5.55e-05	0.00013	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CA—coronary artery disease	5.44e-05	0.000127	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—coronary artery disease	5.4e-05	0.000126	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MAPK1—coronary artery disease	5.29e-05	0.000124	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—coronary artery disease	5.07e-05	0.000119	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT1—coronary artery disease	4.9e-05	0.000114	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASP3—coronary artery disease	4.85e-05	0.000113	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—coronary artery disease	4.82e-05	0.000113	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCND1—coronary artery disease	4.72e-05	0.00011	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CA—coronary artery disease	4.59e-05	0.000107	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—coronary artery disease	4.58e-05	0.000107	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT1—coronary artery disease	4.45e-05	0.000104	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—coronary artery disease	4.12e-05	9.63e-05	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—coronary artery disease	4.07e-05	9.51e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—coronary artery disease	3.78e-05	8.84e-05	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT1—coronary artery disease	3.75e-05	8.77e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK1—coronary artery disease	3.71e-05	8.66e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CA—coronary artery disease	3.22e-05	7.52e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—coronary artery disease	2.85e-05	6.66e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT1—coronary artery disease	2.63e-05	6.14e-05	CbGpPWpGaD
